Cargando…
Treatment Response to SGLT2 Inhibitors: From Clinical Characteristics to Genetic Variations
SGLT2 (sodium-glucose cotransporter 2) inhibitors are a new class of antihyperglycaemic drugs that act on the proximal tubules of the kidney. They have shown efficacy in the management of diabetes mellitus type 2 and their cardiovascular and renal safety have been extensively investigated and confir...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466905/ https://www.ncbi.nlm.nih.gov/pubmed/34575958 http://dx.doi.org/10.3390/ijms22189800 |